Optimi Health Corp. (TSE:OPTI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Optimi Health Corp., a Canadian GMP psychedelics manufacturer, has achieved a milestone by securing an Export Permit from Health Canada to ship its in-house produced MDMA to Tel Aviv University’s Institute for Psychedelic Research, marking its first international export. This move will support the Institute’s study on MDMA’s effects on alcohol addiction, showcasing Optimi’s role in furthering global psychedelic research and innovation.
For further insights into TSE:OPTI stock, check out TipRanks’ Stock Analysis page.